New device offers a real-time view of breast cancer during surgery

It eliminates the need for follow-up surgeries.

Lumicell, an MIT spinout, has developed a handheld device with an optical imaging agent that enables surgeons to see real-time tissue images during surgery. This innovation helps detect residual cancer cells, allowing for more precise tissue removal and potentially reducing the need for follow-up surgeries. During clinical trials, the technology significantly decreased the need for second surgeries and identified tissue likely to contain cancer cells that standard lumpectomy procedures might have overlooked.

Explore more ..

Tesla’s Roadster Could Get SpaceX-Inspired Thrusters

Tesla has proposed rocket-related technology for its electric sports car, but it still needs to prove its capabilities.

AMD’s Venice CPUs Bring 256 Cores to Agentic AI

AMD’s 6th-gen EPYC 9006 processors pair Zen 6 and TSMC’s 2nm process to handle the growing CPU demands of agentic AI.

Samsung Unveils New Memory Tech for AI

Samsung showcases zHBM, zNAND-O and 400-layer V10 BV-NAND at FMS 2026.

Intel Collaborates with Lens Technology on Glass Chip Packaging

The partnership aims to speed up glass substrate manufacturing, a technology expected to power future AI chips, servers, robotics, and edge devices.